New oral drugs for the treatment of multiple sclerosis.

Autor: Chard D; Senior Clinical Research Associate and Honorary Consultant Neurologist in the Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London WC1N 3BG and the National Institute for Health Research Biomedical Research Centre at University College London Hospitals and University College London, London., Trip A; Honorary Senior Lecturer and Consultant Neurologist in the Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London and the National Institute for Health Research Biomedical Research Centre at University College London Hospitals and University College London, London., Chataway J; Reader in Neurology and Consultant Neurologist in the Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London and the National Institute for Health Research Biomedical Research Centre at University College London Hospitals and University College London, London.
Jazyk: angličtina
Zdroj: British journal of hospital medicine (London, England : 2005) [Br J Hosp Med (Lond)] 2016 Sep 02; Vol. 77 (9), pp. 502-3.
DOI: 10.12968/hmed.2016.77.9.502
Databáze: MEDLINE